SCHEMBL102918

SCHEMBL102918

CCOC(C)(OC)N(C(C)(OC)OCC)C(C)(OC)OCC

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.35
TSHR P16473 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6536844 0.85
SCHEMBL3150737 0.81 ALDH1A1 (0.33) ALDH1A1TSHRTDP1
SCHEMBL3151127 0.79 ALDH1A1 (0.32) ALDH1A1TSHRTDP1
SCHEMBL3141273 0.75
SCHEMBL8827236 0.71
SCHEMBL1650987 0.71
SCHEMBL2000782 0.69
SCHEMBL7155207 0.67 ALDH1A1 (0.53) ALDH1A1TSHRTDP1
SCHEMBL46572 0.67
SCHEMBL419791 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1261 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2296039-B1 Positive photosensitive composition FUJIFILM CORP (JP) 2013-09-25 EP claimed
EP-1968606-A2 PREPARATION OF PHARMACEUTICAL SALTS OF 3-O-(3',3'-DIMETHLSUCCINYL) BETULINIC ACID Panacos Pharmaceuticals, Inc. (US) 2008-09-17 EP claimed
US-20070203103-A1 Preparation of pharmaceutical salts of 3-O-(3',3'-dimethylsuccinyl)betulinic acid MYREXIS, INC. 2007-08-30 US claimed
WO-2007078848-A2 PREPARATION OF PHARMACEUTICAL SALTS OF 3-O-(3',3'-DIMETHLSUCCINYL) BETULINIC ACID PANACOS PHARMACEUTICALS, INC. (US) 2007-07-12 WO claimed
US-6713146-B2 SINGLY RECORDABLE COMPACT DISC (CD-R) BAYER AKTIENGESELLSCHAFT (DE) 2004-03-30 US claimed
EP-1322906-A1 OPTICAL DATA STORAGE DEVICE CONTAINING A CO-PHTHALOCYANIN COMPLEX IN THE OPTICALLY WRITABLE INFORMATION LAYER Bayer Aktiengesellschaft (DE) 2003-07-02 EP claimed
US-20020127366-A1 Optical data stores containing a Co-phthalocyanine complex in the information layer recordable using light LANXESS DEUTSCHLAND GMBH (DE) 2002-09-12 US claimed
WO-2002025205-A1 OPTICAL DATA STORAGE DEVICE CONTAINING A CO-PHTHALOCYANIN COMPLEX IN THE OPTICALLY WRITABLE INFORMATION LAYER BAYER AKTIENGESELLSCHAFT (DE) 2002-03-28 WO claimed
US-5853691-A Silver halides of altered crystal habit or morphology and methods for producing same STATE OF OREGON ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION ON THE BEHALF OF THE UNIVERSITY OF OREGON (US) 1998-12-29 US claimed
US-5853686-A Calcium carbonates of altered crystal habit or morphology and methods for producing same STATE OF OREGON ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF OREGON (US) 1998-12-29 US claimed
US-5545394-A REACTING COMPOUNDS IN LIQUID OR GEL TO FORM INSOLUBLE CRYSTALLITE PRODUCTS; USING COMPLEXING AGENT TO FACILITATE DISSOLUTION OF REACTANTS IN SOLVENT THE STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF OREGON (US) 1996-08-13 US claimed
US-12578648-B2 Rinsing liquid and pattern forming method FUJIFILM CORPORATION (JP) 2026-03-17 US disclosed
EP-3435158-B1 ACTIVE RAY-SENSITIVE OR RADIATION-SENSITIVE COMPOSITION, METHOD FOR PURIFYING ACTIVE RAY-SENSITIVE OR RADIATION-SENSITIVE COMPOSITION, PATTERN-FORMING METHOD, AND METHOD FOR PRODUCING ELECTRONIC DEVICE FUJIFILM CORP (JP) 2025-11-19 EP disclosed
US-20250321486-A1 METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE FUJIFILM CORPORATION (JP) 2025-10-16 US disclosed
US-20250271765-A1 METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE FUJIFILM CORPORATION (JP) 2025-08-28 US disclosed
EP-0712326-A4 COMPLEXATION-MEDIATED CRYSTAL-FORMING REACTIONS USING COMPLEXING AGENTS OREGON STATE (US) 1997-11-26 EP disclosed
US-5545394-A REACTING COMPOUNDS IN LIQUID OR GEL TO FORM INSOLUBLE CRYSTALLITE PRODUCTS; USING COMPLEXING AGENT TO FACILITATE DISSOLUTION OF REACTANTS IN SOLVENT THE STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF OREGON (US) 1996-08-13 US disclosed
EP-0712326-A1 COMPLEXATION-MEDIATED CRYSTAL-FORMING REACTIONS USING COMPLEXING AGENTS THE STATE OF OREGON ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF OREGON (US) 1996-05-22 EP disclosed
WO-1995004583-A1 COMPLEXATION-MEDIATED CRYSTAL-FORMING REACTIONS USING COMPLEXING AGENTS THE STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF OREGON (US) 1995-02-16 WO disclosed
US-4902835-A Fluorinated butene derivatives and methods for their preparation THE UNIVERSITY OF ROCHESTER (US) 1990-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12578648-B2 Rinsing liquid and pattern forming method ALKBH5, GABBR1, DNMT3B ALDH1A1 1071/4885TSHR 617/4885TDP1 1792/4885
US-20070203103-A1 Preparation of pharmaceutical salts of 3-O-(3',3'-dimethylsuccinyl)betulinic acid BET1, ERCC5, WASHC5 ALDH1A1 2943/4885TSHR 4786/4885TDP1 504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.